Evidence map›Paper›PMID 20501764›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2010

Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial.

Gerd Bobe, Gwen Murphy, Connie J Rogers, Kenneth W Hance, Paul S Albert, Adeyinka O Laiyemo, Leah B Sansbury, Elaine Lanza, Arthur Schatzkin, Amanda J Cross

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Review
  8. Epidemiology and biology of physical activity and cancer recurrence.Journal of molecular medicine (Berlin, Germany) · 2017
    Review
  9. Article
  10. Article
  11. Body mass index and colon cancer screening: the road ahead.World journal of gastroenterology · 2015
    Review
  12. Review
  13. Article
  14. Association of insulin-related serum factors with colorectal polyp number and type in adult males.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Article
  15. Article
  16. Article
  17. Article
  18. Adiposity factors are not related to the presence of colorectal adenomas.Clinical and experimental gastroenterology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Gerd BobeLaboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute (NCI), NIH, Department of Health and Human Services (DHHS), Bethesda, Maryland, USA. gerd.bobe@oregonstate.edu
Gwen Murphy
Connie J Rogers
Kenneth W Hance
Paul S Albert
Adeyinka O Laiyemo
Leah B Sansbury
Elaine Lanza
Arthur Schatzkin
Amanda J Cross
Health and Human Development (2HD) Research Network · CMNational Cancer Institute · USDivision of Cancer Epidemiology and GeneticsZimmer Biomet (United States) · US

Funding

Lower Gastrointestinal Cancer StudiesZIACP010198 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SINHA, RASHMI · 2009 to 2025
$6.6M
Polyp Prevention Trial Continued Follow-up StudyZ01CN000151 · NCI · CANCER PREVENTION AND CONTROL · PI LANZA, ELAINE · 1990 to 2007
$416k
Intramural NIH HHS Z01 CN000151
6 · The paper itself

Abstract

backgroundSerum adiponectin, leptin, C-peptide, and homocysteine are indicators for obesity, hyperinsulinemia, and chronic inflammation, which have all been associated with colorectal cancer.

aimsTo determine whether serum adiponectin, leptin, C-peptide, and homocysteine are associated with fat, fiber, fruit and vegetable, flavonol, or dry bean intake and colorectal adenoma recurrence.

methodsUsing logistic regression, we estimated odds ratios (OR) and 95% confidence intervals (95% CI) for adenoma recurrence in 627 participants from the control arm of the Polyp Prevention Trial, a 4-year trial that examined the effectiveness of a low-fat, high-fiber, high-fruit and vegetable diet on adenoma recurrence.

resultsSerum concentrations of C-peptide and homocysteine were inversely related to fiber, fruit and vegetable, and flavonol intake and positively related to percentage of calories from fat (all P(trend) < or = 0.01). High homocysteine concentrations were associated with any (4th versus 1st quartile: OR, 2.26; 95% CI, 1.30-3.94) and more than one adenoma recurrence (OR, 2.11; 95% CI, 1.01-4.40). Individuals in the highest, versus lowest, tertile of serum leptin concentration had a decreased risk of advanced adenoma recurrence (OR, 0.22; 95% CI, 0.06-0.79).

conclusionOur results suggest that serum homocysteine may serve as an indicator of dietary exposure, including a low-fat and high-fiber, high-fruit and vegetable, and high-flavonol diet, as well as colorectal adenoma recurrence. IMPACT: Discovering biomarkers that are both modifiable and can predict cancer risk is critical. We identified serum homocysteine as a novel indicator that is modified by diet and predicts risk of adenoma recurrence.

Indexed as

AdenomaAdiponectinAdultAgedAged, 80 and overColorectal NeoplasmsC-PeptideDietFemaleFollow-Up StudiesHomocysteineHumansLeptinMaleMiddle AgedNeoplasm Recurrence, LocalAdiponectinC-PeptideHomocysteineLeptin

Identifiers

PMID20501764
PMCPMC2882997
OpenAlexW2131294347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.